Gts Securities LLC Novavax Inc Call Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $432,568 - $2.33 Million	111,200 Added 68.05%	274,600 $3.48 Million
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $573,400 - $918,049	-152,500 Reduced 48.27%	163,400 $781,000
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $1.02 Million - $1.62 Million	-211,600 Reduced 40.11%	315,900 $1.52 Million
Q3 2023 Nov 15, 2023	BUY	$6.81 - $9.74 $3.59 Million - $5.14 Million	527,500 New	527,500 $3.82 Million

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.